1.A Retrospective Study of Rescue Injuries and Agonal Injuries in 640 Death Cases
Xuanyi LI ; Guoli LV ; Wen YANG ; Chunlei WU ; Xiaoshan LIU ; Bin LUO ; Xinbiao LIAO ; Erwen HUANG
Journal of Sun Yat-sen University(Medical Sciences) 2025;46(1):81-87
[Objective]To clearly identify the difference between rescue injuries and agonal injuries and to avoid duplicate identifications and misidentifications.[Methods]Based on the forensic pathological data of 5 923 cases of death cause identification from 2013 to 2022 in Sun Yat-sen University Forensic Identification Center and Guangzhou Tianhe District Branch of Guangzhou Public Security Bureau,this study retrospectively studied the characteristics of rescue injuries and agonal injuries seen in cause of death identification and their influence on cause of death identification.[Results]Among all the 5 923 cases,640 cases were found to have rescue injuries or agonal injuries,and 624 cases received treatment,of which 609 cases were found to have rescue injuries(97.60%),44 cases were found to have agonal injuries,and 13 cases were found to have both types of injuries.Among the 640 cases,441 were male and 199 were female.The age of death was discontinuously distributed from 0 to 95 years old.The leading cause of death was disease,followed by mechanical injury and asphyxia.The main manifestations of rescue injuries were rib and sternum fractures,soft tissue injuries in the prechest area or face,and pericardial rupture.The most common injuries in agonal stage were falling after unconsciousness,inhalation of foreign body in respiratory tract or multiple violent injuries.Among the 640 cases,19 cases were repeatedly identified,including 15 cases of rescue injuries,6 cases of agonal injuries,and 2 cases of both types of injuries.Compared with the cases where neither type of injuries was detected,the repeated identification rate of treatment injuries and agonal injuries was significantly increased(χ2=4.04,P=0.044;χ2=43.49,P<0.001).Among the 640 cases,11 cases(1.72%)were misidentified as the initial injuries in the first identification,and 13 cases had combined rescue injuries or agonal injuries that were involved in death.[Conclusions]By elucidating the epidemiological characteristics of the two types of injuries,this study proved that the two types of injuries were associated with higher rates of repeated identification and misidentification,which provided a reference for reducing repeated identification and misidentification and improving the accuracy of cause of death identification.
2.Associations between statins and all-cause mortality and cardiovascular events among peritoneal dialysis patients: A multi-center large-scale cohort study.
Shuang GAO ; Lei NAN ; Xinqiu LI ; Shaomei LI ; Huaying PEI ; Jinghong ZHAO ; Ying ZHANG ; Zibo XIONG ; Yumei LIAO ; Ying LI ; Qiongzhen LIN ; Wenbo HU ; Yulin LI ; Liping DUAN ; Zhaoxia ZHENG ; Gang FU ; Shanshan GUO ; Beiru ZHANG ; Rui YU ; Fuyun SUN ; Xiaoying MA ; Li HAO ; Guiling LIU ; Zhanzheng ZHAO ; Jing XIAO ; Yulan SHEN ; Yong ZHANG ; Xuanyi DU ; Tianrong JI ; Yingli YUE ; Shanshan CHEN ; Zhigang MA ; Yingping LI ; Li ZUO ; Huiping ZHAO ; Xianchao ZHANG ; Xuejian WANG ; Yirong LIU ; Xinying GAO ; Xiaoli CHEN ; Hongyi LI ; Shutong DU ; Cui ZHAO ; Zhonggao XU ; Li ZHANG ; Hongyu CHEN ; Li LI ; Lihua WANG ; Yan YAN ; Yingchun MA ; Yuanyuan WEI ; Jingwei ZHOU ; Yan LI ; Caili WANG ; Jie DONG
Chinese Medical Journal 2025;138(21):2856-2858
3.Progress in clinical research of transjugular intrahepatic portosystemic shunt for the treatment of portal cavernous transformation
Jiayang ZHU ; Bing ZHOU ; Xuanyi CHEN ; Junkang WANG ; Bo LI ; Rongqing QIN ; Yubo ZHANG ; Ruochen HU
Journal of Interventional Radiology 2025;34(8):900-904
Clinically,the incidence of portal vein thrombosis(PVT)in patients with cirrhosis can be up to 10%-23%.When PVT is not treated promptly,it may develop to cavernous transformation of the portal vein(CTPV).CTPV can aggravate portal hypertension,accelerate the progression of esophagogastric varices bleeding,refractory ascites,refractory peritonitis,biliary tract diseases,and hepatic insufficiency.At present,noninvasive imaging techniques such as portal vein reconstruction,enhanced CT and ultrasound are mostly used to make the diagnosis and evaluation of CTPV.It is rather difficult to perform portosystemic shunt surgery in patients with CTPV complicated by portal hypertension,which was once regarded as a contraindication for interventional portosystemic shunt procedures.With the improvement of related technologies and surgical instruments,the transjugular intrahepatic portosystemic shunt(TIPS)has become an important treatment for CTPV.This paper aims to make a comprehensive review about the relevant researches concerning the portosystemic shunt surgery in patients with CTPV so as to clarify the importance of TIPS in the treatment of CTPV.
4.Application of subjective gravity detection in vestibular system diseases
Manyu ZHANG ; Caiji WANG ; Xuanyi LI ; Yuehua QIAO
Journal of Audiology and Speech Pathology 2025;33(6):592-596
Subjective visual gravity detection includes subjective visual vertical(SVV)detection and subjec-tive visual horizontal(SVH)detection,which refers to the detection of the angle between patients' perceived gravity vertical line and gravity horizontal line and the actual gravity vertical line and horizontal line when people exclude vis-ual reference and in dark environment.The results are used to evaluate the function of the utricle of the subjects,and then provide the basis for diagnosing vestibular system diseases.With the continuous improvement of SVV &SVH examination technology and the understanding of the mechanism,SVV & SVH examination has been widely applied to clinical work.At present,there are some progresses of srvesvit SVV & SVH in the diagnosis,evaluation and treatment of diseases of the vestibular system such as vestibular neuronitis,Meniere disease and benign paroxys-mal positional vertigo(BPPV),and this article reviews these progresses.
5.The clinical application of fluocinolone acetonide in the management of non-infectious posterior uveitis:interpretation of the European Expert Consensus 2024
Yi SHAO ; Xuanyi LI ; Qian WEI
Recent Advances in Ophthalmology 2025;45(4):253-256
Non-infectious posterior uveitis(NIU-PS) is an ocular inflammatory disease that can cause eye structural damage and vision loss if inflammation reoccurs and is not effectively controlled.Achieving sustained disease control and preventing relapses are the primary therapeutic objectives.Recently,fluocinolone acetonide(FAc) intravitreal implants have received attention as a new local treatment option.Standardizing inflammation management has become a critical con-cern for ophthalmologists.This paper provides a detailed interpretation of the European expert consensus on the use of 0.2μg·d-1 FAc intravitreal implants for the treatment of NIU-PS patients.
6.The clinical application of fluocinolone acetonide in the management of non-infectious posterior uveitis:interpretation of the European Expert Consensus 2024
Yi SHAO ; Xuanyi LI ; Qian WEI
Recent Advances in Ophthalmology 2025;45(4):253-256
Non-infectious posterior uveitis(NIU-PS) is an ocular inflammatory disease that can cause eye structural damage and vision loss if inflammation reoccurs and is not effectively controlled.Achieving sustained disease control and preventing relapses are the primary therapeutic objectives.Recently,fluocinolone acetonide(FAc) intravitreal implants have received attention as a new local treatment option.Standardizing inflammation management has become a critical con-cern for ophthalmologists.This paper provides a detailed interpretation of the European expert consensus on the use of 0.2μg·d-1 FAc intravitreal implants for the treatment of NIU-PS patients.
7.Application of subjective gravity detection in vestibular system diseases
Manyu ZHANG ; Caiji WANG ; Xuanyi LI ; Yuehua QIAO
Journal of Audiology and Speech Pathology 2025;33(6):592-596
Subjective visual gravity detection includes subjective visual vertical(SVV)detection and subjec-tive visual horizontal(SVH)detection,which refers to the detection of the angle between patients' perceived gravity vertical line and gravity horizontal line and the actual gravity vertical line and horizontal line when people exclude vis-ual reference and in dark environment.The results are used to evaluate the function of the utricle of the subjects,and then provide the basis for diagnosing vestibular system diseases.With the continuous improvement of SVV &SVH examination technology and the understanding of the mechanism,SVV & SVH examination has been widely applied to clinical work.At present,there are some progresses of srvesvit SVV & SVH in the diagnosis,evaluation and treatment of diseases of the vestibular system such as vestibular neuronitis,Meniere disease and benign paroxys-mal positional vertigo(BPPV),and this article reviews these progresses.
8.In vivo and in Vitro Component Identification and Pharmacokinetic Analysis of Houpo Wenzhongtang Based on Rats with Deficiency-cold of Spleen and Stomach
Xuanyi SHI ; Jiayi CHEN ; Shu CHEN ; Zixian GU ; Li OUYANG ; Guangyan LUO ; Xiaoshun PENG ; Jianqun LIU
Chinese Journal of Experimental Traditional Medical Formulae 2024;30(17):145-154
ObjectiveTo identify the chemical components of Houpo Wenzhongtang in vivo and in vitro and to analyze the pharmacokinetic properties of the index components in rats with deficiency-cold of spleen and stomach. MethodThe chemical components of Houpo Wenzhongtang was analyzed and identified by ultra performance liquid chromatography-quadrupole-time-of-flight tandem mass spectrometry(UPLC-Q-TOF-MS/MS). Six rats were randomly selected from 18 SD rats as the blank group, and the remaining rats were given lard and cold vinegar for a long time to construct a rat model with deficiency-cold of spleen and stomach. After successful modeling, the rats were randomly divided into the model group and Houpu Wenzhongtang group(13.5 g·kg-1, calculated as crude drug). The administration group was given the corresponding dose of Houpu Wenzhongtang by gavage, and the blank group and the model group were given the same amount of distilled water by gavage. Enzyme-linked immunosorbent assay(ELISA) were used to measure gastrin(GAS) and motilin(MTL) levels in each group. At the same time, plasma samples were collected at different time points after administration, and blood-entry prototype components and metabolites of Houpo Wenzhongtang were analyzed by UPLC-Q-TOF-MS/MS. On this basis, plasma concentrations of magnolol, honokiol, alpinetin and hesperidin in Houpo Wenzhongtang were determined by ultra performance liquid chromatography coupled with triple quadrupole/linear ion trap mass spectrometry(UPLC-QTRAP-MS/MS), and the pharmacokinetic parameters were calculated using DAS 2.0 software. ResultA total of 79 chemical components, including 44 flavonoids and 11 lignans, were identified in Houpo Wenzhongtang. Meanwhile, 18 blood-entry prototype components and 27 metabolites were identified, the main metabolic pathways of metabolites were glucuronidation, sulfation, oxidation and hydrolysis, and phase Ⅰ and phase Ⅱ were the two primary forms of metabolism. Pharmacokinetic results showed that among the four index components, the time to peak(tmax) values of magnolol and honokiol were consistent and exhibited similar drug metabolism characteristics, the tmax of alpinetin was the shortest, and the absorption rate was the fastest, which had the earliest peak plasma concentration levels, and hesperidin had the shortest mean residence time(MRT0-t) and the highest metabolic rate in rats. ConclusionThis study clarifies the blood-entry prototype components and their metabolites of Houpo Wenzhongtang in the rat model of deficiency-cold of spleen and stomach, and reveals the pharmacokinetic characteristics of the main active ingredients, which can provide a scientific basis for the study of pharmacodynamic material basis of this formula and its clinical application in treating the syndrome of deficiency-cold of spleen and stomach.
9.Clinical characteristics and prognostic analysis of systemic lupus erythematosus combined with thrombotic microangiopathy in children
Jianghong DENG ; Xuanyi LIU ; Shipeng LI ; Fengqiao GAO ; Weiying KUANG ; Junmei ZHANG ; Xiaohua TAN ; Chao LI ; Yuan XUE ; Caifeng LI
Chinese Journal of Applied Clinical Pediatrics 2024;39(9):666-671
Objective:To analyze the clinical characteristics of children with systemic lupus erythematosus (SLE) combined with thrombotic microangiopathy (TMA), and clarify the clinical outcomes and related risk factors of pediatric patients through their treatment and follow-up.Methods:This was a single-center retrospective case-control study. Children diagnosed with SLE combined with TMA between January 2017 and January 2023 at Beijing Children′s Hospital, Capital Medical University, were selected as the TMA group, and SLE children without TMA were selected as the control group.According to the prognosis, children in the TMA group were further divided into the good prognosis group and the poor prognosis group.The data of the children were collected, including age, gender, SLE disease activity, clinical presentations at the time of diagnosis and at the time of thrombosis, laboratory examinations, treatment strategies, prognosis, and follow-up results.The chi-square test and Z-test were used for comparison of count data.The t-test was used for comparison of metrological pairing data.The Fisher′s exact test was used to compare the differences between the 2 groups in categorical variables.The univariate Logistic regression was used to analyze the risk factors of poor prognosis. Results:There were 29 cases in the TMA group, and the incidence of TMA accounted for 2.53% of SLE patients; 33 cases were in the control group.The age at diagnosis of TMA was 13 years and 5 months (ranging from 9 years, 1 month and 5 days to 17 years and 4 months).The common clinical manifestations in order of prevalence were renal involvement (28 cases, 96.55%), hematologic involvement (26 cases, 89.66%), serous effusion (17 cases, 58.62%), rash (13 cases, 44.82%), and neurologic involvement (12 cases, 41.38%).Pleurisy or pericarditis, renal involvement and neurological involvement occurred more often in the TMA group than in the control group (17 cases vs.3 cases, 28 cases vs.10 cases, 12 cases vs.3 cases), and the TMA group showed less facial rash and arthritis than the control group (13 cases vs.25 cases, 4 cases vs.17 cases), and the differences were statistically significant (all P<0.05).The Systemic Lupus Erythematosus Disease Activity Index score in the TMA group [(24.14±9.42) scores] was significantly higher than that in the control group [(10.18±9.42) scores], and the difference was statistically significant ( t=3.233, P<0.05).The hemoglobin level, platelet count, and complement C3 level of the children in the TMA group were significantly lower than those in the control group, whereas the double stranded DNA antibody, lactate dehydrogenase, D-dimer, urea, creatinine, ferritin level, and urine protein quantitation were significantly higher than those in the control group, and the differences were statistically significant (all P<0.05).In the TMA group, 5 cases had decreased ADAMTS13 activity, and 5 cases had significantly increased complement C5b9.A total of 15 cases (51.72%) in the TMA group underwent renal biopsy, and 13 of them had combined renal TMA.In the TMA group, 28 patients (96.6%) received hormone therapy, 17 patients received plasma exchange, and 12 patients were treated with immunosuppressants and biologics; 19 patients (65.5%) improved, and 10 patients (34.5%) gave up the treatment due to deterioration of the disease.The urea level and peripheral blood fragmented erythrocyte rate in the good prognosis group were significantly lower than those in the poor prognosis group [(13.18±4.39) mmol/L vs.(21.16±10.14) mmol/L, t=2.975, P=0.006; 8/17 (47.06%) vs.7/7 (100%), χ2=5.929, P=0.015].The univariate Logistic regression analysis showed that the fragmented erythrocyte, ADAMTS13 activity and urea were the independent risk factors for poor prognosis (all P<0.05). Conclusions:SLE patients with moderate-to-severe disease activity, especially children with hemolytic anemia, thrombocytopenia, and renal dysfunction as prominent manifestations, should be alert to the risk of TMA.Early diagnosis and treatment are crucial.
10.Research progress of the screening and generation of lead compounds based on artificial intelligence model
Zhihao GU ; Wenhao GUO ; Hequan YAO ; Xuanyi LI ; Kejiang LIN
Journal of China Pharmaceutical University 2023;54(3):294-304
Excellent lead compounds have a profound influence on drug development and can improve the success rate of product launch. It is expensive and time-consuming to discover lead compounds by traditional methods, yet artificial intelligence (AI) can discover good lead compounds efficiently.This article systematically summarizes the research progress of obtaining lead compounds through the screening and generation models of AI, classifies different models according to the type of information input, focuses on drug repurposing by screening model and multi-objective drug design by generation model, and discusses the development prospect of AI in the research field of lead compounds, aiming to provide new research ideas for the application of AI in lead compounds.

Result Analysis
Print
Save
E-mail